Hwang M H, Sihdu P, Pacold I, Johnson S, Scanlon P J, Loeb H S
Section of Cardiology, Hines Veterans Administration Hospital, IL 60141.
Am Heart J. 1988 Feb;115(2):297-301. doi: 10.1016/0002-8703(88)90473-5.
Thirty-nine patients underwent coronary arteriography 1 to 20 months (mean 7 months) after percutaneous transluminal coronary angioplasty (PTCA). At the time of the repeat study, 35 patients (90%) had recurrent angina or myocardial infarction, and 4 patients (10%) were asymptomatic. Restenosis, defined as greater than 50% loss of PTCA gained diameter, was found in 19 patients (49%). In addition, 20 patients had new lesions or marked progression of existing lesions (defined as greater than 20% or increasing greater than 20% obstruction in coronary diameter) in the previously normal or mildly diseased coronary segments. The new or progressive lesions occurred both in patients with restenosis at the PTCA site (nine of 19) and in patients without restenosis (11 of 20). New or progressive lesions tended to occur more commonly in the artery on which PTCA was performed (13 of 40) than in the artery that did not have PTCA (10 of 77) (p less than 0.02 by chi 2). In arteries that had PTCA, new or progressive lesions occurred more often in the segment proximal to the angioplasty site (seven of 13 or 54%) than in the peri-PTCA segment (two of 13 or 15%) and in the segments distal to it (four of 13 or 31%), but this observation did not reach statistical significance. No other clinical, angiographic, or PTCA procedure variables affected the occurrence of new or progressive lesions. In patients with recurrent angina or myocardial infarction after PTCA, both restenosis and new or progressive lesions are common. New lesions or marked progression of existing lesions tended to occur in the vessel subjected to PTCA.(ABSTRACT TRUNCATED AT 250 WORDS)
39例患者在经皮腔内冠状动脉成形术(PTCA)后1至20个月(平均7个月)接受了冠状动脉造影。在重复研究时,35例患者(90%)有复发性心绞痛或心肌梗死,4例患者(10%)无症状。19例患者(49%)发现再狭窄,定义为PTCA获得的管径丧失超过50%。此外,20例患者在先前正常或轻度病变的冠状动脉节段出现新病变或现有病变显著进展(定义为冠状动脉直径阻塞大于20%或增加大于20%)。新病变或进展性病变在PTCA部位发生再狭窄的患者中(19例中的9例)和未发生再狭窄的患者中(20例中的11例)均有出现。新病变或进展性病变在接受PTCA的动脉中(40例中的13例)比未接受PTCA的动脉中(77例中的10例)更常见(χ²检验p<0.02)。在接受PTCA的动脉中,新病变或进展性病变在血管成形术部位近端节段(13例中的7例或54%)比在PTCA周围节段(13例中的2例或15%)和其远端节段(13例中的4例或31%)更常出现,但这一观察结果未达到统计学显著性。没有其他临床、血管造影或PTCA操作变量影响新病变或进展性病变的发生。在PTCA后有复发性心绞痛或心肌梗死的患者中,再狭窄以及新病变或进展性病变都很常见。新病变或现有病变的显著进展往往发生在接受PTCA的血管中。(摘要截短于250字)